Awards

Outstanding Scientific Achievement Award - Jiandie Lin, PhD

2020 Outstanding Scientific Achievement Award

Jiandie Lin, PhD

Outstanding Scientific Achievement Award Lecture
"Emerging Endocrine and Paracrine Hormones in Health and Metabolic Disease"

Jiandie Lin, PhD, is the recipient of the 2020 Outstanding Scientific Achievement Award. This prestigious award recognizes research in diabetes that demonstrates independence of thought and originality.  Dr. Lin will present the Outstanding Scientific Achievement Award Lecture on Monday, June 15. 

Dr. Lin received his Bachelor of Science biochemistry from Peking University (1994) and his doctorate in biochemistry and molecular biology and cell biology from Northwestern University (2000).

His postdoctoral work with Dr. Bruce Spiegelman revealed insights into the role of the PGC-1 transcriptional coactivators in mitochondrial oxidative metabolism and metabolic physiology. In 2005, Dr. Lin started his independent research career in the Department of Cell & Developmental Biology and Life Sciences Institute at the University of Michigan. Dr. Lin’s research interfaces the basic biology of metabolic signaling, pathophysiology of metabolic disease, and therapeutic development. His lab explored the mechanisms through which chromatin regulators link nutritional signaling to metabolic gene programs. Dr. Lin’s group pioneered the discovery of several emerging endocrine factors and single-cell mapping of metabolic tissue microenvironment in health and disease.  

Dr. Lin has received the American Diabetes Association’s Career Development Award, Bradley M. Patten Collegiate Professorship, and Dean’s Basic Science Award at the University of Michigan Medical School. Dr. Lin was elected a fellow of American Association for the Advancement of Science in 2018. He has been an active member of the diabetes research community and currently serves as an associate editor of Diabetes. 

Please join us in celebrating Jiandie Lin, PhD, for his transformative contributions to basic and translational diabetes research.